The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2022 2
2012 1
2011 1

U.S. 1
United States 1

Journal Article 5

1 - 5 of 5 Results

Refine Results

Refine Results:

Cefepime-Resistant Pseudomonas aeruginosa

CITE Title : Cefepime-Resistant Pseudomonas aeruginosa Personal Author(s) : Akhabue, Ehimare;Synnestvedt, Marie;Weiner, Mark G.;Bilker, Warren B.;Lautenbach, Ebbing; Published Date : Jun 2011 Source : Emerg Infect Dis. 17(6):1037-1043. URL : https://stacks.cdc.gov/view/cdc/18279 Akhabue, Ehimare et al. (2011). Cefepime-Resistant Pseudomonas aeruginosa. 17(6). Akhabue, Ehimare et al. "Cefepime-Resistant Pseudomonas aeruginosa" 17, no. 6 (2011) Akhabue, Ehimare et al. "Cefepime-Resistant Pseudomonas aeruginosa" vol. 17, no. 6, 2011 Export RIS Citation Information.

:

Akhabue, Ehimare ;

Synnestvedt, Marie

Jun 2011 | Emerg Infect Dis. 17(6):1037-1043.

:

Resistance to extended-spectrum cephalosporins complicates treatment of Pseudomonas aeruginosa infections. To elucidate risk factors for cefepime-resi...
Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Escherichia coli and Klebsiella Species in Hospitalized Patients

CITE Title : Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Escherichia coli and Klebsiella Species in Hospitalized Patients Personal Author(s) : Han, Jennifer H.;Nachamkin, Irving;Zaoutis, Theoklis E.;Coffin, Susan E.;Linkin, Darren R.;Fishman, Neil O.;Weiner, Mark G.;Hu, Baofeng;Tolomeo, Pam;Lautenbach, Ebbing; Published Date : Oct 23 2012 Source : Infect Control Hosp Epidemiol. 2012; 33(12):1242-1245. URL : https://stacks.cdc.gov/view/cdc/33677 Han, Jennifer H. et al. (2012). Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Escherichia coli and Klebsiella Species in Hospitalized Patients. 33(12). Han, Jennifer H. et al. "Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Escherichia coli and Klebsiella Species in Hospitalized Patients" 33, no. 12 (2012) Han, Jennifer H. et al. "Risk Factors for Gastrointestinal Tract Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Escherichia coli and Klebsiella Species in Hospitalized Patients" vol. 33, no. 12, 2012 Export RIS Citation Information.

:

Han, Jennifer H. ;

Nachamkin, Irving

Oct 23 2012 | Infect Control Hosp Epidemiol. 2012; 33(12):1242-1245.

:

We describe the prevalence of and risk factors for colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella s...
Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021

CITE Title : Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021 Personal Author(s) : Wiltz, Jennifer L.;Feehan, Amy K.;Molinari, NoelleAngelique M.;Ladva, Chandresh N.;Truman, Benedict I.;Hall, Jeffrey;Block, Jason P.;Rasmussen, Sonja A.;Denson, Joshua L.;Trick, William E.;Weiner, Mark G.;Koumans, Emily;Gundlapalli, Adi;Carton, Thomas W.;Boehmer, Tegan K.; Published Date : 1 21 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 71(3):96-102 DOI : http://dx.doi.org/10.15585/MMWRmm7103e1 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Wiltz, Jennifer L. et al. (2022). Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021. 71(3). http://dx.doi.org/10.15585/MMWRmm7103e1 Wiltz, Jennifer L. et al. "Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021" 71, no. 3 (2022), http://dx.doi.org/10.15585/MMWRmm7103e1 Wiltz, Jennifer L. et al. "Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — U.S. March 2020–August 2021" vol. 71, no. 3, 2022, http://dx.doi.org/10.15585/MMWRmm7103e1 Export RIS Citation Information.

:

Wiltz, Jennifer L. ;

Feehan, Amy K.

1 21 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

The COVID-19 pandemic has magnified longstanding health care and social inequities, resulting in disproportionately high COVID-19-associated illness a...
Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021

CITE Title : Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021 Personal Author(s) : Wiltz, Jennifer L.;Feehan, Amy K.;Molinari, NoelleAngelique M.;Ladva, Chandresh N.;Truman, Benedict I.;Hall, Jeffrey;Block, Jason P.;Rasmussen, Sonja A.;Denson, Joshua L.;Trick, William E.;Weiner, Mark G.;Koumans, Emily;Gundlapalli, Adi;Carton, Thomas W.;Boehmer, Tegan K.; Corporate Authors(s) : CDC COVID-19 Response Team. Published Date : January 14, 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/113480 Wiltz, Jennifer L. et al. (2022). Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021. 71 Wiltz, Jennifer L. et al. "Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021" 71 (2022) Wiltz, Jennifer L. et al. "Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021" vol. 71, 2022 Export RIS Citation Information.

:

Wiltz, Jennifer L. ;

Feehan, Amy K.

January 14, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Racial and ethnic disparities in SARS-CoV-2 infection risk and death from COVID-19 have been well documented.W...
Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018–2022

CITE Title : Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018–2022 Personal Author(s) : Jackson, Sandra L.;Lekiachvili, Akaki;Block, Jason P.;Richards, Thomas B.;Nagavedu, Kshema;Draper, Christine C.;Koyama, Alain K.;Womack, Lindsay S.;Carton, Thomas W.;Mayer, Kenneth H.;Rasmussen, Sonja A.;Trick, William E.;Chrischilles, Elizabeth A.;Weiner, Mark G.;Podila, Pradeep S. B.;Boehmer, Tegan K.;Wiltz, Jennifer L.; Corporate Authors(s) : on behalf of PCORnet Network Partners Published Date : 7 03 2024 Source : Prev Chronic Dis. 2024; 21 DOI : http://dx.doi.org/10.5888/pcd21.230415 Journal Title : Preventing Chronic Disease (PCD) Jackson, Sandra L. et al. (2024). Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018–2022. 21http://dx.doi.org/10.5888/pcd21.230415 Jackson, Sandra L. et al. "Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018–2022" 21 (2024), http://dx.doi.org/10.5888/pcd21.230415 Jackson, Sandra L. et al. "Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018–2022" vol. 21, 2024, http://dx.doi.org/10.5888/pcd21.230415 Export RIS Citation Information.

:

Jackson, Sandra L. ;

Lekiachvili, Akaki

7 03 2024 | Prev Chronic Dis. 2024; 21

:

BackgroundData modernization efforts to strengthen surveillance capacity could help assess trends in use of preventive services and diagnoses of new c...